Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 76

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 76
---
RL Instance Document-the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document101.SCHInline XBRL Taxonomy Extension Schema Document101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document101.LABInline XBRL Taxonomy Extension Label Linkbase Document101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document101.DEFInline XBRL Taxonomy Extension Definitions Linkbase Document104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

#    Management contract or compensatory plan, contract, or arrangement

+    Confidential treatment has been granted as to certain portions, which portions have been omitted and submitted separately to the Securities and Exchange Commission. 

^    Portions of this exhibit have been redacted pursuant to Regulation S-K Item 601(b)(10)(iv).

Item 16. Form 10-K Summary

Not applicable.

-95-

GLOSSARY

This Glossary includes acronyms and defined terms that are used throughout this report.

ABC: Acinetobacter baumannii-calcoaceticus complex

ABSSSI: Acute bacterial skin and skin structure infections

AChR: Anti-acetylcholine receptor

AD: Atopic dermatitis 

ADC: Antibody-drug conjugate

ADP: Psychosis associated with Alzheimer’s Disease 

ADS: American Depositary Share, each representing ten of the Company’s ordinary shares

Amgen: Amgen Inc.

Archives Rules: Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering and Listing by Domestic Companies

argenx: argenx BV

ASC: Accounting Standard Codification 

Asia Pacific: Refers to Greater China, Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan, collectively

Audit Committee: The Audit Committee of the Board of Directors

AUGTYRO (Repotrectinib): A next-generation TKI of ROS proto-oncogene 1 (ROS1) tyrosine-protein kinase and of the tropomyosin receptor tyrosine kinases (TRKs) TRKA, TRKB, and TRKC

Bemarituzumab: A humanized anti-FGFR2b IgG1 monoclonal antibody

Bemarituzumab FPA144-004 Study: A global Phase III registrational trial of bemarituz